Want to take quizzes and track your credits?
lets you earn AMA PRA Category 1 CME Credit™ from a source you trust, JAMA Network. Find relevant articles, audio, video, and interactives, track your progress, and print certificates—all while deepening your knowledge of the topic at hand. Learn more
In this post hoc Bayesian analysis of the EOLIA trial comparing the effects on mortality of venovenous extracorporeal membrane oxygenation (ECMO) vs conventional mechanical ventilation for management of severe acute respiratory distress syndrome (ARDS), the posterior probability of mortality benefit (relative risk <1) ranged between 88% and 99% given a range of prior assumptions reflecting varying degrees of skepticism and enthusiasm regarding previous evidence for the benefit of ECMO. Ewan C. Goligher, MD, PhD, of the University of Toronto in Canada presents findings from the analysis at the European Society of Intensive Care Medicine (ESICM) 31st Annual Congress, LIVES 2018, on October 22 in Paris. Used with permission.
You currently have no searches saved.